Orion Infusion Limited reported earnings results for the third quarter and nine months ended March 31, 2023. For the third quarter, the company reported sales was BDT 183.28 million compared to BDT 181.41 million a year ago. Net income was BDT 7.81 million compared to BDT 9.15 million a year ago. Basic earnings per share from continuing operations was BDT 0.38 compared to BDT 0.45 a year ago.
For the nine months, sales was BDT 607.27 million compared to BDT 612.15 million a year ago. Net income was BDT 28.76 million compared to BDT 29.14 million a year ago. Basic earnings per share from continuing operations was BDT 1.41 compared to BDT 1.43 a year ago.